Drug Appears to Prolong Survival in Stomach Cancer Patients

THURSDAY, Aug. 19 — Use of the drug trastuzumab in addition to chemotherapy can extend stomach cancer patients’ survival by nearly three months, a new study has found. However, an editorial accompanying the study questions whether the treatment is cost-effective. The study and comment were both published in the Aug. Read more…

THURSDAY, Aug. 19 — Use of the drug trastuzumab in addition to chemotherapy can extend stomach cancer patients’ survival by nearly three months, a new study has found.

However, an editorial accompanying the study questions whether the treatment is cost-effective. The study and comment were both published in the Aug.

Read more…